Levosalbutamol

左沙丁胺醇

Report date: 2023/01/13 20:00:32

Base Information

Drug NameLevosalbutamol
Drug Alias Name(R)-Albuterol tartrate左沙丁胺醇酒石酸盐(-)-Salbutamol tartrateLevosalbutamol tartrateLevalbuterol tartrate +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsBronchial Spasm
Global Approved IndicationsBronchial Spasm
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSunovion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesLupin Ltd
Inactive CompaniesN/A
Active IndicationsBronchial Spasm
Inactive IndicationsN/A

Other Information

ATC CodeR03AC02
Related LinksWikipediaDrugBankKEGG